tirzepatide hrv Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Personalized Compounded Tirzepatide Treatment

However, a 2021 study compared weight loss after using the drug or placebo (6)

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Eat Weight Disord 29, 64 (2024)

A higher dose of 1mg is available if further blood sugar control is needed

Contrary to the beneficial findings in basic studies, where GLP-1 analogs could alleviate metabolic lesions in the retina's parenchyma or vessel bed and demonstrate neural protective effects, the discrepancy between preclinical results and real-world practice has sparked safety concerns about expanding their use

doi: 10.1016/j.jhep.2019.04.017 233 HuangXZhangYTangY